.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Pre-congress: 8th ESMRMB-GREC meeting

8th ESMRMB-GREC meeting
Clinical indications and safety of GBCA-enhanced MRI

Mission 1

Termin

Datum: 04.10.2023

Zeit: 08:30 – 11:15

Ort / Stream:

Room Nairobi

Moderator

Programm

08:30 – 08:45 15 Min. 0 Min.
Lecture
Gadolinium-based contrast agents in the diagnosis and monitoring of the ear and internal auditory canal
Marinella Neri (Trento, IT)
Andrea Falzone (Rovereto, IT)
08:45 – 09:00 0 Min. 15 Min.
Discussion
GREC Discussion
09:00 – 09:15 15 Min. 0 Min.
Lecture
Gadolinium use reduction strategies in the clinical setting – state-of-the-art – ESUR-CMSC joint initiative
Ilona A. Dekkers (Amsterdam, NL)
09:15 – 09:30 15 Min. 0 Min.
Lecture
ESUR-CMSC and ESMRMB-GREC Joint Working Group on GBCA Dose Reduction in MRI – Technical MRI optimisation
Aart J. van der Molen (Leiden, NL)
09:30 – 09:50 0 Min. 20 Min.
Discussion
GREC Discussion
09:50 – 10:00 10 Min. 0 Min.
Lecture
Multiorgan and plasma metabolomics for the investigation of the biological effects of gadodiamide and gadoteridol in healthy mice
Eliana Gianolio (Turin, IT)
10:00 – 10:10 10 Min. 0 Min.
Lecture
Evaluating gadolinium-induced histopathological alterations related to small fiber neuropathy and gadolinium clearance following repeated GBCA administration in rats
Hubertus Pietsch (Bayer, DE)
10:10 – 10:20 10 Min. 0 Min.
Lecture
Investigation of the gadolinium distribution in human nerves by mass spectrometric imaging
Christine Verlemann (Münster, DE)
Astrid Jeibmann (Münster, DE)
Uwe Karst (Münster, DE)
10:20 – 10:30 10 Min. 0 Min.
Lecture
Disability and long-term clinical outcome in patients with Multiple Sclerosis and evidence of gadolinium retention in the brain
Sirio Cocozza (Naples, IT)
10:30 – 10:40 10 Min. 0 Min.
Lecture
Imaging of meningeal lymphatics with standard clinical MRI and intravenous GBCA administrations
Michael Stringer (Edinburgh, GB)
10:40 – 10:50 10 Min. 0 Min.
Lecture
MultiCriteria Decision Analysis (MCDA) model for GBCA
Anand Bherwani (GE HealthCare)
François Tranquart (GE HealthCare)
10:50 – 11:15 0 Min. 25 Min.
Discussion
Questions and remarks

8th ESMRMB-GREC meetingClinical indications and safety of GBCA-enhanced MRI

Termin

Moderator

Programm

8th ESMRMB-GREC meeting
Clinical indications and safety of GBCA-enhanced MRI